Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2017

  • ID: 4410311
  • Report
  • 520 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3M Co
  • CB Scientific Inc.
  • FluGen Inc
  • Microdermics Inc
  • Ratio Inc
  • TheraSolve NV
  • MORE
Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Transdermal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transdermal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Co
  • CB Scientific Inc.
  • FluGen Inc
  • Microdermics Inc
  • Ratio Inc
  • TheraSolve NV
  • MORE
1 Table of Contents

2 Introduction
2.1 Transdermal Drug Delivery Devices Overview

3 Products under Development
3.1 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery Devices - Pipeline Products by Segment
3.3 Transdermal Drug Delivery Devices - Pipeline Products by Territory
3.4 Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery Devices - Ongoing Clinical Trials

4 Transdermal Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Devices Companies and Product Overview
5.1 3M Co Company Overview
5.2 4P Therapeutics LLC Company Overview
5.3 Actuated Medical Inc Company Overview
5.4 Aequus Pharmaceuticals Inc Company Overview
5.5 Agile Therapeutics Inc Company Overview
5.6 Allergan Plc Company Overview
5.7 Alliqua BioMedical Inc Company Overview
5.8 Altea Therapeutics Corporation (Inactive) Company Overview
5.9 AMW GmbH Company Overview
5.10 Apogee Technology Inc Company Overview
5.11 Apricus Biosciences Inc Company Overview
5.12 Aquavit Pharmaceuticals Inc Company Overview
5.13 AstraZeneca Plc Company Overview
5.14 Avro Life Sciences Company Overview
5.15 Axxia Pharmaceuticals, LLC Company Overview
5.16 Burke Pharmaceuticals LLC Company Overview
5.17 CB Scientific Inc. Company Overview
5.18 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview
5.19 Chrono Therapeutics Inc Company Overview
5.20 Corium International Inc Company Overview
5.21 DBV Technologies SA Company Overview
5.22 Dermisonics, Inc. Company Overview
5.23 Dharma Therapeutics, Inc. (Inactive) Company Overview
5.24 DURECT Corp Company Overview
5.25 Echo Therapeutics Inc Company Overview
5.26 Emplicure AB Company Overview
5.27 Endo International Plc Company Overview
5.28 Extend Biosciences Inc Company Overview
5.29 EyeGate Pharmaceuticals Inc Company Overview
5.30 Fe3 Medical Inc Company Overview
5.31 FluGen Inc Company Overview
5.32 French National Institute of Health and Medical Research Company Overview
5.33 Hisamitsu Pharmaceutical Co Inc Company Overview
5.34 ImmuPatch Company Overview
5.35 Imperial College London Company Overview
5.36 Indian Institute of Science Company Overview
5.37 Indian Institute of Technology Bombay Company Overview
5.38 InMed Pharmaceuticals Inc Company Overview
5.39 Institute of Materials Research & Engineering Company Overview
5.40 Intercell AG (Inactive) Company Overview
5.41 Interstitial NS Company Overview
5.42 Isis Biopolymer, Inc. Company Overview
5.43 Janisys Company Overview
5.44 Kalvista Pharmaceuticals Inc Company Overview
5.45 KTH Royal Institute of Technology Company Overview
5.46 Kyowa Hakko Kirin Co Ltd Company Overview
5.47 Massachusetts Institute of Technology Company Overview
5.48 Mayne Pharma International Pty Ltd Company Overview
5.49 Medherant Ltd Company Overview
5.50 MEDRx Co Ltd Company Overview
5.51 mesoestetic USA Inc Company Overview
5.52 Microdermics Inc Company Overview
5.53 Micropoint Technologies Pte Ltd Company Overview
5.54 National Taiwan Ocean University Company Overview
5.55 Nemaura Pharma Ltd Company Overview
5.56 NeuroDerm Ltd Company Overview
5.57 Nitto Denko Corp Company Overview
5.58 North Carolina State University Company Overview
5.59 Novosanis NV Company Overview
5.60 Nuvo Pharmaceuticals Inc Company Overview
5.61 Old Dominion University Company Overview
5.62 Pain Therapeutics Inc Company Overview
5.63 Pantec Biosolutions AG Company Overview
5.64 Phosphagenics Ltd Company Overview
5.65 Purdue University Company Overview
5.66 Radius Health Inc Company Overview
5.67 Ratio Inc Company Overview
5.68 Scilex Ltd Company Overview
5.69 Sensile Medical AG Company Overview
5.70 Skinject Inc Company Overview
5.71 Sparsha Pharma International Pvt Ltd Company Overview
5.72 Sparsha Pharma USA Inc Company Overview
5.73 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.74 Stanford University Company Overview
5.75 Sumitomo Dainippon Pharma Co Ltd Company Overview
5.76 Sun Pharma Advanced Research Company Ltd Company Overview
5.77 Syntropharma Ltd Company Overview
5.78 Taho Pharmaceuticals Ltd Company Overview
5.79 Teikoku Pharma USA Inc Company Overview
5.80 Teikoku Seiyaku Co Ltd Company Overview
5.81 tesa Labtec GmbH Company Overview
5.82 Teva Pharmaceutical Industries Ltd Company Overview
5.83 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
5.84 TheraJect Inc Company Overview
5.85 TheraSolve NV Company Overview
5.86 Theratech, Inc. Company Overview
5.87 Titan Pharmaceuticals Inc Company Overview
5.88 Transcu Group Limited (Inactive) Company Overview
5.89 Transdermal Delivery Solutions Corp Company Overview
5.90 TransPharma Medical Ltd (Inactive) Company Overview
5.91 Transport Pharmaceuticals Inc Company Overview
5.92 TSRL Inc Company Overview
5.93 Univec, Inc. (Inactive) Company Overview
5.94 University of Illinois at Chicago Company Overview
5.95 University of Toronto Company Overview
5.96 Vyteris, Inc. (Inactive) Company Overview
5.97 Yale University Company Overview
5.98 Zambon Italia Srl Company Overview
5.99 Z-Cube Srl Company Overview
5.100 Zosano Pharma Corp Company Overview
5.101 Zynerba Pharmaceuticals Inc Company Overview

6 Transdermal Drug Delivery Devices - Recent Developments
6.1 Sep 20, 2017: DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
6.2 Sep 19, 2017: FluGen Announces Expanded Role for Clinical Advisory Board: Dr. Robert Belshe to Chair
6.3 Sep 18, 2017: National Institute on Drug Abuse Awards Pain Therapeutics $2.2 Million Grant
6.4 Sep 14, 2017: Intarcia and Numab Reach Key Milestone with Selection of Multi-specific Development Candidate for Autoimmune Disease
6.5 Sep 12, 2017: FDA Acknowledges Receipt Of Sorrento Therapeutics NDA For ZTlido; PDUFA Date Set For February 28, 2018
6.6 Sep 11, 2017: Teva Names Kare Schultz as President and Chief Executive Officer
6.7 Sep 11, 2017: The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts
6.8 Sep 07, 2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch
6.9 Sep 07, 2017: Agile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive Medicine
6.10 Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth
6.11 Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors
6.12 Sep 05, 2017: FluGen Announces C. Boyd Clarke Has Been Named Executive Chairman
6.13 Sep 01, 2017: Start of MRX-4TZT Phase I a' Clinical Trial in the United States
6.14 Aug 31, 2017: Kyowa Hakko Kirin: Announcement of submission of supplemental new drug application for the addition of a new 0.5mg dose of the transdermal, long-acting pain relief patch FENTOS TAPE
6.15 Aug 31, 2017: Aquavit's iMicrotox (IMX-001) Study Receives IRB Approval
6.16 Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
6.17 Aug 29, 2017: Sorrento Therapeutics Submits NDA For ZTlidoNext-Generation Lidocaine Patch
6.18 Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights
6.19 Aug 24, 2017: Titan Pharmaceuticals Receives FDA Clearance To Begin Clinical Study Of Parkinson's Disease Treatment
6.20 Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole
6.21 Aug 23, 2017: Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018
6.22 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.23 Aug 11, 2017: SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
6.24 Aug 11, 2017: Valeritas Reports Second Quarter 2017 Financial Results
6.25 Aug 10, 2017: Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update
6.26 Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results
6.27 Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results
6.28 Aug 08, 2017: DURECT Announces Second Quarter 2017 Financial Results and Provides Corporate Update
6.29 Aug 08, 2017: Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook
6.30 Aug 08, 2017: Antares Pharma Reports Second Quarter 2017 Operating And Financial Results
6.31 Aug 07, 2017: EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
6.32 Aug 03, 2017: Teva Reports Second Quarter 2017 Financial Results
6.33 Aug 03, 2017: Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion
6.34 Aug 03, 2017: Revance Releases Second Quarter 2017 Results
6.35 Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017
6.36 Aug 01, 2017: EyeGate Pharma Enrolls First Patient in Phase 2b Clinical Study of EGP-437 for Cataract Surgery
6.37 Jul 31, 2017: Perrigo Announces Launch Of AB Rated Generic Version Of Transderm Scop 1.5 mg
6.38 Jul 31, 2017: SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs
6.39 Jul 28, 2017: Agile Therapeutics Reports Second Quarter 2017 Financial Results
6.40 Jul 27, 2017: Agile Therapeutics Announces FDA Acceptance Of The NDA Resubmission Of Twirla
6.41 Jul 27, 2017: UCB with a strong first half year 2017 - giving rise to the financial outlook for 2017
6.42 Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group
6.43 Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK
6.44 Jul 25, 2017: Lilly Reports Second-Quarter Results
6.45 Jul 25, 2017: 3M Delivers Second-Quarter Sales of $7.8 Billion and Earnings of $2.58 per Share; Company Updates Its 2017 Outlook
6.46 Jul 23, 2017: Teva to Terminate Around 300 jobs in Israel
6.47 Jul 21, 2017: GSK announces Board and Committee changes
6.48 Jul 19, 2017: Joseph H. Boccuzi Appointed to Allergan Board of Directors
6.49 Jul 18, 2017: Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
6.50 Jul 17, 2017: Lannett Appoints Samuel H. Israel As General Counsel
6.51 Jul 13, 2017: Camurus: Interim report January-June 2017
6.52 Jul 13, 2017: Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders
6.53 Jul 06, 2017: Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
6.54 Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch
6.55 Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S.

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
Table 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
Table 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
Table 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Table 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials
Table 7: Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
Table 8: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 9: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
Table 10: 3M Hollow Microstructured Transdermal System - Product Status
Table 11: 3M Hollow Microstructured Transdermal System - Product Description
Table 12: 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Transdermal FSH Patch - Product Status
Table 14: Transdermal FSH Patch - Product Description
Table 15: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: GentleDispense System - Product Status
Table 17: GentleDispense System - Product Description
Table 18: Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: AQS1301 - Product Status
Table 20: AQS1301 - Product Description
Table 21: AQS1302 - Product Status
Table 22: AQS1302 - Product Description
Table 23: AQS1303 - Product Status
Table 24: AQS1303 - Product Description
Table 25: AQS1304 - Product Status
Table 26: AQS1304 - Product Description
Table 27: Aequus Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 28: AQS1301 - Phase Ia Study of AQS-1301 in Healthy Subjects
Table 29: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: AG200-ER Patch - Product Status
Table 31: AG200-ER Patch - Product Description
Table 32: AG200-SP Patch - Product Status
Table 33: AG200-SP Patch - Product Description
Table 34: AG890 Patch - Product Status
Table 35: AG890 Patch - Product Description
Table 36: Twirla (AG200-15) - Product Status
Table 37: Twirla (AG200-15) - Product Description
Table 38: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Nanotechnology-Based Transdermal Delivery System - Product Status
Table 40: Nanotechnology-Based Transdermal Delivery System - Product Description
Table 41: Norethindrone Transdermal Delivery System - Product Status
Table 42: Norethindrone Transdermal Delivery System - Product Description
Table 43: Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: PHN Patch - Product Status
Table 45: PHN Patch - Product Description
Table 46: Altea Therapeutics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 47: PassPort Exenatide Transdermal Delivery System - Product Status
Table 48: PassPort Exenatide Transdermal Delivery System - Product Description
Table 49: Transdermal Enoxaparin Sodium Patch - Product Status
Table 50: Transdermal Enoxaparin Sodium Patch - Product Description
Table 51: Transdermal Fentanyl Citrate Patch - Product Status
Table 52: Transdermal Fentanyl Citrate Patch - Product Description
Table 53: Transdermal Protein Patch - Product Status
Table 54: Transdermal Protein Patch - Product Description
Table 55: AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Rotigotine Patch - Product Status
Table 57: Rotigotine Patch - Product Description
Table 58: Transdermal Patch - Breast Cancer - Product Status
Table 59: Transdermal Patch - Breast Cancer - Product Description
Table 60: Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: PyraDerm - Product Status
Table 62: PyraDerm - Product Description
Table 63: Apricus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Vitaros - Product Status
Table 65: Vitaros - Product Description
Table 66: Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: iMicrotox - Product Status
Table 68: iMicrotox - Product Description
Table 69: Aquavit Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 70: iMicrotox - Efficacy of iMicrotox to Treat Mild-to-moderate Peri-orbital Rhytids
Table 71: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 72: EMLA Patch - Product Status
Table 73: EMLA Patch - Product Description
Table 74: Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Transdermal Drug Delivery Patch - Product Status
Table 76: Transdermal Drug Delivery Patch - Product Description
Table 77: Axxia Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Drug Delivery Implant - Product Status
Table 79: Drug Delivery Implant - Product Description
Table 80: Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 81: BLU402 Hydrogel Patch Wart Kit - Product Status
Table 82: BLU402 Hydrogel Patch Wart Kit - Product Description
Table 83: Drug Delivery Patch - Product Status
Table 84: Drug Delivery Patch - Product Description
Table 85: CB Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Pain-Patch - Product Status
Table 87: Pain-Patch - Product Description
Table 88: Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Topical Diclofenac Patch - Product Status
Table 90: Topical Diclofenac Patch - Product Description
Table 91: Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Biologically-Timed Drug Delivery Device - Product Status
Table 93: Biologically-Timed Drug Delivery Device - Product Description
Table 94: Corium International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Corplex Donepezil Transdermal System - Product Status
Table 96: Corplex Donepezil Transdermal System - Product Description
Table 97: Corplex Memantine Transdermal System - Product Status
Table 98: Corplex Memantine Transdermal System - Product Description
Table 99: Corplex Ropinirole Transdermal System - Product Status
Table 100: Corplex Ropinirole Transdermal System - Product Description
Table 101: MicroCor Transdermal System - Product Status
Table 102: MicroCor Transdermal System - Product Description
Table 103: MicroCor Zolmitriptan System - Product Status
Table 104: MicroCor Zolmitriptan System - Product Description
Table 105: MicroJet - Product Status
Table 106: MicroJet - Product Description
Table 107: Corium International Inc - Ongoing Clinical Trials Overview
Table 108: Corplex Donepezil Transdermal System - A Phase I Crossover Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of Two Formulations of a 7-day Application Donepezil Transdermal Delivery System (TDS) Compared to Oral Administration of Aricept in Healthy Volunteers
Table 109: Corplex Donepezil Transdermal System - A Study to Assess the Steady-state Bioequivalence of Once-weekly Corplex Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept
Table 110: Corplex Donepezil Transdermal System - Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease
Table 111: DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Viaskin Peanut - Product Status
Table 113: Viaskin Peanut - Product Description
Table 114: DBV Technologies SA - Ongoing Clinical Trials Overview
Table 115: Viaskin Peanut - A Double-blind, Placebo-controlled, Randomized Phase 3 Pivotal Trial to Assess the Efficacy and Safety of Peanut Epicutaneous Immunotherapy with Viaskin Peanut in Peanut-allergic Children
Table 116: Viaskin Peanut - A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
Table 117: Viaskin Peanut - Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
Table 118: Viaskin Peanut - Safety Study of Viaskin Peanut to Treat Peanut Allergy (REALISE)
Table 119: Dermisonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 120: U-Strip - Product Status
Table 121: U-Strip - Product Description
Table 122: Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 123: Iontophoretic Drug Delivery Patch - Product Status
Table 124: Iontophoretic Drug Delivery Patch - Product Description
Table 125: DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 126: Eladur - Product Status
Table 127: Eladur - Product Description
Table 128: Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 129: Prelude SkinPrep System - Product Status
Table 130: Prelude SkinPrep System - Product Description
Table 131: Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview
Table 132: Micro-needle Patch - Product Status
Table 133: Micro-needle Patch - Product Description
Table 134: Tamper Resistant Patch - Product Status
Table 135: Tamper Resistant Patch - Product Description
Table 136: Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Rivastigmine Patch - Product Status
Table 138: Rivastigmine Patch - Product Description
Table 139: Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Non-Invasive Needle-Free Skin Patch - Product Status
Table 141: Non-Invasive Needle-Free Skin Patch - Product Description
Table 142: EyeGate Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 143: EyeGate II Delivery System - Product Status
Table 144: EyeGate II Delivery System - Product Description
Table 145: EyeGate Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 146: EyeGate II Delivery System - A Prospective, Multi-center, Randomized, Double-masked, Positive Controlled, Phase III Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients with Non-infectious Anterior Segment Uveitis
Table 147: EyeGate II Delivery System - Multi-center, Double-masked, Randomized, Placebo-controlled Phase IIb Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Having Undergone Cataract Surgery with Implantation of a Posterior Chamber Intraocular Lens (IOL)
Table 148: Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 149: Iron Supplement Patch - Product Status
Table 150: Iron Supplement Patch - Product Description
Table 151: FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 152: FLUGEN 101.2 Microneedle-based Delivery Device - Product Status
Table 153: FLUGEN 101.2 Microneedle-based Delivery Device - Product Description

List of Figures
Figure 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Figure 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
Figure 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
Figure 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
Figure 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Co
  • 4P Therapeutics LLC
  • Actuated Medical Inc
  • Aequus Pharmaceuticals Inc
  • Agile Therapeutics Inc
  • Allergan Plc
  • Alliqua BioMedical Inc
  • Altea Therapeutics Corporation
  • AMW GmbH
  • Apogee Technology Inc
  • Apricus Biosciences Inc
  • Aquavit Pharmaceuticals Inc
  • AstraZeneca Plc
  • Avro Life Sciences
  • Axxia Pharmaceuticals, LLC
  • Burke Pharmaceuticals LLC
  • CB Scientific Inc.
  • Cerimon Pharmaceuticals, Inc.
  • Chrono Therapeutics Inc
  • Corium International Inc
  • DBV Technologies SA
  • Dermisonics, Inc.
  • Dharma Therapeutics, Inc.
  • DURECT Corp
  • Echo Therapeutics Inc
  • Emplicure AB
  • Endo International Plc
  • Extend Biosciences Inc
  • EyeGate Pharmaceuticals Inc
  • Fe3 Medical Inc
  • FluGen Inc
  • French National Institute of Health and Medical Research
  • Hisamitsu Pharmaceutical Co Inc
  • ImmuPatch
  • Imperial College London
  • Indian Institute of Science
  • Indian Institute of Technology Bombay
  • InMed Pharmaceuticals Inc
  • Institute of Materials Research & Engineering
  • Intercell AG
  • Interstitial NS
  • Isis Biopolymer, Inc.
  • Janisys
  • Kalvista Pharmaceuticals Inc
  • KTH Royal Institute of Technology
  • Kyowa Hakko Kirin Co Ltd
  • Massachusetts Institute of Technology
  • Mayne Pharma International Pty Ltd
  • Medherant Ltd
  • MEDRx Co Ltd
  • mesoestetic USA Inc
  • Microdermics Inc
  • Micropoint Technologies Pte Ltd
  • National Taiwan Ocean University
  • Nemaura Pharma Ltd
  • NeuroDerm Ltd
  • Nitto Denko Corp
  • North Carolina State University
  • Novosanis NV
  • Nuvo Pharmaceuticals Inc
  • Old Dominion University
  • Pain Therapeutics Inc
  • Pantec Biosolutions AG
  • Phosphagenics Ltd
  • Purdue University
  • Radius Health Inc
  • Ratio Inc
  • Scilex Ltd
  • Sensile Medical AG
  • Skinject Inc
  • Sparsha Pharma International Pvt Ltd
  • Sparsha Pharma USA Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stanford University
  • Sumitomo Dainippon Pharma Co Ltd
  • Sun Pharma Advanced Research Company Ltd
  • Syntropharma Ltd
  • Taho Pharmaceuticals Ltd
  • Teikoku Pharma USA Inc
  • Teikoku Seiyaku Co Ltd
  • tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd
  • The Sheikh Zayed Institute for Pediatric Surgical Innovation
  • TheraJect Inc
  • TheraSolve NV
  • Theratech, Inc.
  • Titan Pharmaceuticals Inc
  • Transcu Group Limited
  • Transdermal Delivery Solutions Corp
  • TransPharma Medical Ltd
  • Transport Pharmaceuticals Inc
  • TSRL Inc
  • Univec, Inc.
  • University of Illinois at Chicago
  • University of Toronto
  • Vyteris, Inc.
  • Yale University
  • Zambon Italia Srl
  • Z-Cube Srl
  • Zosano Pharma Corp
  • Zynerba Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll